DigiCon

@csrf

@if (isset(session()->get('doctor')['vCentralCode']))

Back

@else

@endif

A survey to assess the usage pattern of Rivastigmine in the management of dementia in Alzheimer’s Disease patients in India

Survey Questionnaire Form

Doctor's details

Questionnaire

How many patients of Alzheimer’s patient do you see in a month? *

<10

11-20

21-30

31-40

Any other

From your clinical experience, mention the most common symptoms patients present to you at diagnosis? *

What is your primary goal in managing dementia symptoms in Alzheimer's patients? *

Improve memory and cognitive function

Slow down the progression of symptoms

Improve patient quality of life

Manage behavioral symptoms

Any other

What challenges do you face with your current treatment options (i.e. Donepezil, Memantine etc.)? *

How do you adjust the treatment plan based on the disease progression? *

As per experience, what is your treatment plan in cases of patients with cognitive impairment? *

Do you consider Rivastigmine as a first-line treatment for Alzheimer’s Disease? *

Yes

What percentage of your Alzheimer’s Disease patients are currently prescribed Rivastigmine? *

10 – 15%

16 – 30 %

31 – 50 %

51 – 75%

76 – 100 %

In your experience, how effective do you find Rivastigmine in managing Alzheimer’s Disease symptoms in comparison to other alternatives available in the market? *

On a scale of 1 to 5, How satisfied are you with the current dosing option for Rivastigmine? (5 being very satisfied) *

In your experience, which dosage form of Rivastigmine do you prefer for Alzheimer's disease patients? *

Capsule

Transdermal patch

Both

Typically, what is the preferred oral dose of rivastigmine for initial therapy for Alzheimer disease patients? *

1.5 mg BID

3 mg BID

4.5 mg BID

6 mg BID

Any Other

In your experience, how quickly do patients typically respond to Rivastigmine treatment? *

1 - 15 days

16 - 30 days

31 - 45 days

46 - 60 days

Any other

Which factors are critical for choosing Rivastigmine in Alzheimer’s Disease? *

In your experience, how long do your patients may need to remain on Rivastigmine treatment?

3 months

6 months

1 year

Any Other

As per your experience, can you see improvements in formulation / delivery of Rivastigmine for enhancement of patient adherence?

Yes

In your experience, can the Rivastigmine provide long-term benefits for Alzheimer’s Disease patients? *

Yes

Not sure

Which age group have you observed most differences in treatment response after prescribing Rivastigmine in Alzheimer’s Disease patients? *

45-60 years

> 60 years

If any other age range

Have you observed any differences in treatment response based on patient’s gender when prescribing Rivastigmine in Alzheimer’s Disease patients? *

Male

Female

Both

{{--

Any other

--}}

How often do you schedule follow-up appointments with patients after initiating Rivastigmine treatment? *

1 month

2-3 months

6 months

1 year or more

What percentage of your patients report satisfactory compliance with Rivastigmine capsule treatment? *

0-25%

26-50%

51-75%

76-100%

How do you typically monitor the effectiveness of Rivastigmine treatment in your patients? *

Alzheimer Disease Assessment Scale (ADAS)

Mini-Mental State Exam (MMSE)

Both

Clinical assessment

Any Other

How satisfied are your patients with the response of the Rivastigmine capsule in managing Alzheimer’s Disease? (5 being very satisfied) *

Do you find Rivastigmine more effective than other medications commonly prescribed for Alzheimer’s Disease patients? *

Yes

Not sure

What percentage of adult patients are exhibiting satisfactory tolerance with Rivastigmine? *

up to 10%

10-20%

20-30%

30-40%

40-50%

Any other

What percentage of your Alzheimer’s Disease patients experience significant improvement in quality of life with Rivastigmine? *

up to 25%

26 - 50%

51 - 75%

76 - 100%

In your experience, do patients with Alzheimer’s Disease having comorbidities influence your decision to prescribe Rivastigmine and Why? *

Based on your experience, do you think additional research is needed to better understand Rivastigmine in Alzheimer’s Disease management? *

Yes

In your opinion, what advantage does Rivastigmine offer over other drugs in Alzheimer’s Disease management? *

How would you rate your overall experience with prescribing Rivastigmine in Alzheimer’s Disease management? (5 being very satisfied) *